MedPath

Standardization Of Ashwakanchuki Rasa And Its Clinical Efficacy In The Management Of Tamaka Shwasa(Bronchial Asthma)

Not yet recruiting
Conditions
Bronchial Asthama
Registration Number
CTRI/2017/01/007635
Lead Sponsor
JS Ayurveda Mahavidhyalaya
Brief Summary

Patients having classical symptoms of Tamaka shwasa ( bronchial asthama )will be enrolled and administered with AKR-001 & AKR-002 in the dose of 125 mg BD with Ardraka swarasa and honey respectively  for 4 weeks. Necessary investigation will be done before and after the treatment.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
30
Inclusion Criteria

Mild persistent case of Asthma (as per WHO gina guidelines) with duration of more than 6 months.

Exclusion Criteria
  • Patient having pneumonia, lung collapse, pneumothorax, parenchymal lung disease, lower respiratory tract infection, pleural effusion, lung cancer, lung abscess and other complicated condition.
  • •HIV positive case.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
the patients will be followed for 4 week.4 weeks
Secondary Outcome Measures
NameTimeMethod
Patients will be reviewed after 15 days of completion of the treatment.15 days

Trial Locations

Locations (1)

J.S.Ayurveda college

🇮🇳

Kheda, GUJARAT, India

J.S.Ayurveda college
🇮🇳Kheda, GUJARAT, India
vidhi M Shukla
Principal investigator
9428803009
vidhishukla16@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.